Totrombopag

Drug Profile

Totrombopag

Alternative Names: 559448; SB-559448; SB-559448-AAA

Latest Information Update: 13 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ligand Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Thrombopoietin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Thrombocytopenia

Most Recent Events

  • 13 Mar 2007 SB 559448 is still in phase I trials for thrombocytopenia in the US
  • 24 Nov 2005 Phase-I clinical trials in Thrombocytopenia in USA (unspecified route)
  • 06 Jul 2005 Preclinical trials in Thrombocytopenia in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top